David Bejker
Director/Board Member at ABLIVA AB
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Eskil Elmér | M | 54 | 24 years | |
| Carl Erik Mathias Uhlén | M | 70 |
Affibody AB
 Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden.
Affibody Medical AB
 Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | 26 years |
| Catharina Jz Johansson | F | 57 | 11 years | |
| Daniel Lifveredson | M | 48 | 7 years | |
| Jenni Björnulfson | F | 53 | 3 years | |
| Karin Hansson | M | 61 |
Amylonix AB
 Amylonix AB Pharmaceuticals: MajorHealth Technology Amylonix AB develops pharmaceuticals focused on the neurodegenerative area. Amylonix AB is based in Johanneshov, Sweden. It was founded in 2018 by Karin Marianne Hansson, who has been the CEO since 2018. | 6 years |
| David Laskow-Pooley | M | 69 | 8 years | |
| Lars-Inge Sjöqvist | M | 62 | - | |
| Joachim Feldwisch | M | - |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | - |
| Denise Goode | F | 66 | 6 years | |
| Johan Stuart | M | 67 |
Affibody AB
Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | - |
| Karin Nord | M | - |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | 26 years |
| Johan Lund | M | 67 | 2 years | |
| Maria Ada Eufemia Forss | F | 52 | 9 years | |
| Jan Birger Fredrik Toernell | M | 64 | 7 years | |
| Sven Peter Torbjörn Browall | M | 62 | - | |
| Stig Anders Lindberg | M | 52 |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden.
Affibody AB
Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | - |
| Jose F. Suarez | M | 54 |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | - |
| Kia Bengtsson | F | - | 2 years | |
| Gillian Cannon | M | 60 |
Affibody AB
Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | 5 years |
| Camilla Soenderby | F | - |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | - |
| Eleonor Asander Frostner | F | 43 | 13 years | |
| Ellen Donnelly | M | 50 | 3 years | |
| Roger Franklin | M | 45 | 4 years | |
| Magnus Hansson | M | 48 | 16 years | |
| Karl Anders Axel Swartling | M | 59 |
Affibody AB
Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | - |
| Anders Martin-Löf | M | 53 |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | 3 years |
| Niklas Axén | M | 61 | 20 years | |
| Robert Forbes Burns | M | 77 |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | - |
| J. Kenneth Charles Knowles | M | 77 |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | - |
| Erik Walldén | M | 75 |
Affibody AB
Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | - |
| Dag Nesse | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Anna Yvonne Monica Malm Bernsten | F | 63 | 4 years | |
| Carl-Gustaf Gölander | M | 71 | - | |
| Matthew Lindon | M | 51 | 1 years | |
| Matilda Hugerth | F | 49 | 5 years | |
| Gunnar Magnus Modee Persson | M | 64 | 2 years | |
| Max Håkan Mitteregger | M | 61 | 1 years | |
| Derek Gregory Batcheller | M | 67 | 17 years | |
| Arne Ferstad | M | 74 | 7 years | |
| Erik Kinnman | M | 66 | 5 years | |
| Anja Peters Ohlsson | F | 54 | 2 years | |
| Anders Månsson | M | 57 | 1 years | |
| Marie Helena Levander | F | 67 | 5 years | |
| Charlotta Gauffin | M | 53 | 3 years | |
| Daniel Schale | M | - | 1 years | |
| Stefan Grudén | M | 52 | - | |
| Nina Herne | M | 55 | 1 years | |
| Anders Sigvard Bjartell | M | 65 | 7 years | |
| Gerd Inga-Lill Forslund Larsson | F | 70 | 7 years | |
| Mark Farmery | M | 55 | 3 years | |
| Bengt Norvik | M | 69 | 4 years | |
| Markus Thor | M | 53 | - | |
| Marcus Keep | M | 65 | 18 years | |
| Monica Kristina Wallter | M | 68 | 6 years | |
| Boel Flodgren | M | 82 | 4 years | |
| Johan Georg Harmenberg | M | 70 | 2 years | |
| Annette Møldrup | M | 63 | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Sweden | 58 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David Bejker
- Personal Network
